|AHFS/Drugs.com||International Drug Names|
|By mouth (tablets)|
|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||315.41 g/mol g·mol−1|
|3D model (JSmol)|
|(what is this?)|
Mitiglinide belongs to the meglitinide (glinide) class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda. The North America rights to mitiglinide are held by Elixir Pharmaceuticals. Mitiglinide has not yet gained FDA approval.
Mitiglinide is delivered in tablet form.